Search

Home > New FDA Approvals > 073 – Plecanatide for IBS-C; FDA panel rejects Philip Morris's claims that new smokeless cigarette reduces harm; Flu season may peak in coming weeks
Podcast: New FDA Approvals
Episode:

073 – Plecanatide for IBS-C; FDA panel rejects Philip Morris's claims that new smokeless cigarette reduces harm; Flu season may peak in coming weeks
Category: Science & Medicine
Duration: 00:10:01
Publish Date: 2018-01-26 07:00:00
Description:

January 26, 2018

0:53 - Plecanatide for IBS-C https://ir.synergypharma.com/press-releases/detail/1861/synergy-pharmaceuticals-announces-fda-approval-of 

3:10 - FDA panel rejects Philip Morris's claims that new smokeless cigarette reduces harm https://www.washingtonpost.com/news/to-your-health/wp/2018/01/25/fda-panel-rejects-philip-morriss-claims-that-new-smokeless-cigarette-reduces-harm/?utm_term=.1639fc547e88 

5:14 - Flu season may peak in coming weeks, FDA chief says https://www.cnbc.com/2018/01/25/flu-season-may-peak-in-coming-weeks-fda-chief-says.html

This podcast's website: NewFDAapprovals.com

Nascent Medical nascentmc.com

AI Medicine podcast – AIMedicineNews.com
Total Play: 0